Results 11 to 20 of about 295,792 (196)

Esophageal Adenocarcinoma

open access: yes, 2018
This vital collection provides a unique set of techniques to explore the clinical, pathological, and research aspects of the management of patients with esophageal adenocarcinoma. Beginning with an introduction to the basic features of esophageal adenocarcinoma, the book continues with clinical protocols for the management of the cancer, pathological ...
Lam, Alfred
core   +5 more sources

The study of molecular markers for the progression of Barrett's Oesophagus to adenocarcinoma to identify markers that can be used as diagnostic tools. [PDF]

open access: yes, 2002
Barrett's oesophagus is a complication of gastro-oesophageal reflux disease and is the single most important predisposing factor for the development of adenocarcinoma of the oesophagus.
Cadd, Verity Anne
core   +7 more sources

Current status and future perspectives on the etiology of esophageal adenocarcinoma

open access: yesFrontiers in Oncology, 2012
Esophageal adenocarcinoma is the most common type of esophageal cancer in most Western countries and is an important contributor to overall cancer mortality.
Aaron P. Thrift   +3 more
doaj   +1 more source

CA19-9-producing esophageal adenocarcinoma originating from the esophageal cardia of the mid-thoracic esophagus: a case report

open access: yesSurgical Case Reports, 2021
Background Although there are many studies on primary esophageal adenocarcinoma arising from Barrett's esophagus or ectopic gastric mucosa, reports on adenocarcinoma arising from esophageal cardiac glands are extremely rare.
Naoki Kuwayama   +11 more
doaj   +1 more source

Human Microbiota in Esophageal Adenocarcinoma: Pathogenesis, Diagnosis, Prognosis and Therapeutic Implications

open access: yesFrontiers in Microbiology, 2022
Esophageal adenocarcinoma (EAC) is one of the main subtypes of esophageal cancer. The incidence rate of EAC increased progressively while the 5-year relative survival rates were poor in the past two decades.
Wanyue Dan   +5 more
doaj   +1 more source

Preliminary evaluation for Bit1 as a potential biomarker for squamous cell carcinoma and adenocarcinoma of esophagus

open access: yesTumor Biology, 2017
Mounting evidence has demonstrated that Bit1 has been investigated as an etiological factor for certain cancers, including esophageal squamous cell carcinoma reported in our previous study, but data regarding possible roles of Bit1 in esophageal squamous
Jing Chen   +8 more
doaj   +1 more source

Advances in the study of esophageal adenocarcinoma cell lines, model develpoment and 3D culture technology [PDF]

open access: yesJichu yixue yu linchuang, 2020
Esophageal adenocarcinoma is a uncommon malignant tumor. The deterioration and metastasis of esophageal adenocarcinoma bring some difficulties and challenges to the treatment of tumor.
LIU Dong-jian, YANG Ling
doaj  

Esophageal Adenocarcinoma: Opportunities for Targeted Prevention in Ohio

open access: yesClinical Medicine Insights: Gastroenterology, 2018
Objective: The incidence of esophageal adenocarcinoma, one of the most lethal gastroenterological diseases, has been increasing since the 1960s. Prevention of esophageal adenocarcinoma is important because no early detection screening programs have been ...
Julie A Stephens   +5 more
doaj   +1 more source

Toll-like receptors in esophageal cancer

open access: yesFrontiers in Immunology, 2014
Esophageal squamous cell carcinoma and esophageal adenocarcinoma are cancers of high mortality. Esophageal adenocarcinoma develops through Barrett’s esophagus and columnar dysplasia, preceded by gastroesophageal reflux disease.
Joonas H Kauppila   +5 more
doaj   +1 more source

Management of esophageal adenocarcinoma

open access: yesJournal of Visceral Surgery, 2011
The incidence of esophageal adenocarcinoma is increasing in Western countries with a tendency to exceed that of squamous-cell carcinoma. Prognosis is unfavorable with 5-year survival less than 15%, irrespective of treatment and the stage. At the time of diagnosis, more than two thirds of patients have a non-operable cancer because of extension or ...
D, Tougeron, J-P, Richer, C, Silvain
openaire   +2 more sources

Home - About - Disclaimer - Privacy